Results 151 to 160 of about 21,002 (186)

Cracking the resistance code: The molecular reclassification of cancer and precision therapy strategies. [PDF]

Semin Cancer Biol
Nikanjam M, Kurzrock R.
europepmc   +1 more source

Phosphorylation-Inducing Molecules for Regulating Dynamic Cellular Processes. [PDF]

J Am Chem Soc
Pergu R, Sreekanth V, Kokkonda P, Lai S, Tiwari PK, Singh S, Kawai J, Singha S, Tian W, Thimaradka V, Siriwongsup S, Tran K, Choudhary A.   +12 more
europepmc   +1 more source

Exploring the Allosteric Pathways of Asciminib in the Dual Inhibition of BCR-ABL1. [PDF]

Biomolecules
Ming J, Gao H, Zhan J.
europepmc   +1 more source

Clinical, morphological and genetic characteristics of patients with concurrent presence of JAK2 V617F and BCR::ABL1. [PDF]

Sci Rep
Naumann N, Dangelo V, Lübke J, Bresser J, Hagen V, Dengler J, Metzgeroth G, Kreil S, Hockenberger T, Hofmann WK, Fabarius A, Saussele S, Cross NCP, Reiter A, Schwaab J.   +14 more
europepmc   +1 more source

Engineering of photo-inducible binary interaction tools for biomedical applications. [PDF]

Nat Commun
Lee YT, Guo L, Lan TH, Nonomura T, Liu G, Ma G, Wang R, Huang Y, Zhou Y.   +8 more
europepmc   +1 more source

Current Status of Molecularly Targeted Therapeutics in Blood Cancers. [PDF]

Int J Mol Sci
Kumala C, Vu L, Fandy TE.
europepmc   +1 more source

Structure and Dynamics of the ABL1 Tyrosine Kinase and Its Important Role in Chronic Myeloid Leukemia. [PDF]

Arch Pharm (Weinheim)
Irgit A, Kamıs R, Sever B, Tuyun AF, Otsuka M, Fujita M, Demirci H, Ciftci H.   +7 more
europepmc   +1 more source

Unlocking the Potential of Perillaldehyde: A Novel Mechanism for Chronic Myeloid Leukemia by Targeting HSP70. [PDF]

Molecules
Zhang M, Wang J, Jiang R, Liu M, Zhang W.   +4 more
europepmc   +1 more source

Tracking leukemic residuals: dissecting the inverse relationship between CD26+ stem cells and extracellular BCR::ABL1 transcript in Chronic Myeloid Leukemia (CML). [PDF]

Stem Cells Transl Med
Mutti S, Cavalleri A, Sicuranza A, Pacelli P, Ielo C, Paolini L, Mangolini V, Leoni A, Miracapillo T, Turriziani C, Abruzzese E, Farina M, Radeghieri A, Malagola M, Breccia M, Bocchia M, Russo D, Bernardi S.   +17 more
europepmc   +1 more source

Src and Abl as Therapeutic Targets in Lung Cancer: Opportunities for Drug Repurposing. [PDF]

Pharmaceuticals (Basel)
Ramos R, Sousa C, Vale N.
europepmc   +1 more source